Increasing the age of brain: Effect of Androgen Deprivation Therapy (ADT) exposure on brain and cognition

Increasing the age of brain: Effect of Androgen Deprivation Therapy (ADT) exposure on brain and cognition

Bibliographic Details
Main Authors:	A.C. Plata Bello, Y. Perez Martin, V. Fajardo, T. Concepción Masip, J. Plata Bello
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320335217

Similar Items

Changes in resting-state measures of prostate cancer patients exposed to androgen deprivation therapy
by: Julio Plata-Bello, et al.
Published: (2021-12-01)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study
by: Hiroji Uemura, et al.
Published: (2022-01-01)

Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis.
by: Tobias Engel Ayer Botrel, et al.
Published: (2016-01-01)

Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
by: Zeina Ayoub, et al.
Published: (2022-12-01)

Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
by: A. Gomez-Iturriaga, et al.
Published: (2024-03-01)

Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis
by: C. Garcia Alvarez, et al.
Published: (2020-07-01)

Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers
by: Choi E, et al.
Published: (2022-03-01)

Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial
by: Tao Wang, et al.
Published: (2022-09-01)

ADT-3D Tumor Detection Assistant in 3D
by: Jaime Lazcano Bello, et al.
Published: (2008-12-01)

Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study.
by: Milena Braga-Basaria, et al.
Published: (2023-01-01)

The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma
by: S. Acosta-Lopez, et al.
Published: (2020-12-01)

ARCHES: Efficacy of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC) by prior local and systemic treatment
by: A. Stenzl, et al.
Published: (2020-07-01)

The effect on quality of life of androgen deprivation therapy (ADT) combined with local external prostate radiotherapy in patients with primary metastatic prostate cancer, results from the HORRAD trial
by: L.M.S. Boevé, et al.
Published: (2020-07-01)

346 KEYNOTE-991: phase 3 study of pembrolizumab plus enzalutamide and androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
by: Christian Poehlein, et al.
Published: (2020-11-01)

Androgen Receptor Activity Is Associated with Worse Survival in Glioblastoma
by: Helga Fariña-Jerónimo, et al.
Published: (2022-04-01)

De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)
by: Ted A. Skolarus, et al.
Published: (2018-11-01)

Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood
by: Allison B. Reiss, et al.
Published: (2023-12-01)

Impact of androgen deprivation therapy on cognitive function in men with prostate cancer
by: Yutaka Yamamoto, et al.
Published: (2024-03-01)

Brain-Selective Estrogen Therapy Prevents Androgen Deprivation-Associated Hot Flushes in a Rat Model
by: Istvan Merchenthaler, et al.
Published: (2020-06-01)

Multimodal therapy in urachal carcinoma with oligometastatic bone disease
by: C. García Alvarez, et al.
Published: (2019-09-01)

Pleomorphic malignant fibrous histiocytoma in bladder diverticulum
by: C. García Alvarez, et al.
Published: (2020-01-01)

Analysis of Brain Functions in Men with Prostate Cancer under Androgen Deprivation Therapy: A One-Year Longitudinal Study
by: Vanessa Sánchez-Martínez, et al.
Published: (2021-03-01)

Androgen deprivation therapy and the risk of subsequent keratitis
by: Dai-Wei Liu, et al.
Published: (2021-01-01)

Effects of androgen deprivation on brain function in prostate cancer patients – a prospective observational cohort analysis
by: Chao Herta H, et al.
Published: (2012-08-01)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
by: Iya Eze Bassey, et al.
Published: (2020-11-01)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
by: Shimajiri Shohei, et al.
Published: (2011-05-01)

Androgen Deprivation Therapy for Prostate Cancer Influences Body Composition Increasing Risk of Sarcopenia
by: Jolanta Korczak, et al.
Published: (2023-03-01)

Sleep Deprivation Induces Cognitive Impairment by Increasing Blood-Brain Barrier Permeability via CD44
by: Jing Sun, et al.
Published: (2020-11-01)

ADTs, data structures, and problem solving with C++ /
by: 252203 Nyhoff, Larry R.
Published: (2005)

ADT: The automatic weather station data tool
by: Rija Faniriantsoa, et al.
Published: (2022-08-01)

Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
by: Myungsun Shim, et al.
Published: (2022-03-01)

Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
by: Giovanni Corona, et al.
Published: (2021-07-01)

EFFECTS OF BRAIN AGE TO INCREASE COGNITIVE FUNCTION IN ELDERLY
by: Achdiat Agoes, et al.
Published: (2016-07-01)

Androgen deficiency is associated with a better prognosis in glioblastoma
by: Helga Fariña-Jerónimo, et al.
Published: (2024-01-01)

Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.
by: Shiu-Dong Chung, et al.
Published: (2017-01-01)

Androgen deprivation therapy (castration therapy) and pedophilia: What’s new
by: Mauro Silvani, et al.
Published: (2015-09-01)

Prediction of brain age and cognitive age: quantifying brain and cognitive maintenance in aging
by: Anatürk, M, et al.
Published: (2020)

Brain Activity Correlates With Cognitive Performance Deterioration During Sleep Deprivation
by: Hugo F. Posada-Quintero, et al.
Published: (2019-09-01)

Brain functions and cognition on transient insulin deprivation in type 1 diabetes
by: Ana L. Creo, et al.
Published: (2021-03-01)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
by: Shtutman Michael, et al.
Published: (2010-04-01)